Resources

Psoriasis Treatments and Unmet Needs

Home | Resources

Research Objectives:

  • Understand what physicians currently know about products in development for moderate to severe psoriasis
  • Explore how physicians are currently treating their moderate to severe psoriasis patients
  • Better understand unmet needs in moderate to severe psoriasis

Methodology:
Method: 5-minute MicroSurvey via InCrowd
Crowds: US Dermatologists
Sample Size: n=75
Inclusion Criteria/Screeners: Qualified respondents are US-based Dermatologists who:
• Have treated at least 20 moderate to severe psoriasis patients in the past three months
• Are aware of products in development for moderate to severe psoriasis
Fielding Period: November 21-26, 2018

One key finding: Unmet needs for treatment of this condition include a need for oral therapies with improved clinical profiles (both in safety and efficacy), increased affordability for patients, and treatments that achieve long-term remission.

Download the full report now!

Please fill out the form below to access this content

Related Resources

IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more